US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist
  • 6.650
  • -0.320-4.59%
Close Feb 18 16:00 ET
  • 6.980
  • +0.330+4.96%
Post 16:25 ET
277.91MMarket Cap-2.15P/E (TTM)

About Zenas BioPharma Company

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Company Profile

SymbolZBIO
Company NameZenas BioPharma
Listing DateSep 13, 2024
Issue Price17.00
Founded2019
CEOMr. Leon O. Moulder, Jr
MarketNASDAQ
Employees114
Fiscal Year Ends12-31
Address852 Winter Street,Suite 250
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Websitehttps://www.zenasbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Leon O. Moulder, Jr
  • Chief Executive Officer and Chairman of the Board
  • 2.60M
  • Jennifer A. Fox
  • Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
  • 2.57M
  • Orlando Oliveira
  • Chief Commercial Officer
  • --
  • Joseph Farmer
  • President and Chief Operating Officer
  • 1.29M
  • Ting Xiao
  • Independent Director
  • --
  • Dr. John J. Orloff, M.D.
  • Independent Director
  • --
  • Patricia L. Allen
  • Independent Director
  • --
  • James P. Boylan, M.B.A.
  • Independent Director
  • --
  • Tomas Kiselak
  • Independent Director
  • --
  • Patrick G. Enright, M.B.A.
  • Independent Director
  • --
  • Dr. Hongbo Lu, PhD
  • Independent Director
  • --
  • Jake R. Nunn
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025